Abio stock alert: halper sadeh llc is investigating whether the merger of arca biopharma, inc. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the merger of arca biopharma, inc. (nasdaq: abio) and oruka therapeutics is fair to arca shareholders. upon closing of the proposed transaction, arca shareholders are expected to own approximately 2.38% of the combined company. halper sadeh encourages arca shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sa.
ABIO Ratings Summary
ABIO Quant Ranking